Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -8 of 8 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 7/1/1991


1.		Phase II Trial of Deoxyspergualin in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 07/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				any age				NCI				MSKCC-90152 NCI-T90-0225C, T90-0225

Last Modified: 7/1/1991


2.		Phase II Study of DSG Followed by a Salvage Regimen of CDDP/VP-16 in Patients with Extensive Small Cell Lung Cancer (Summary Last Modified 07/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				MDA-DM-90101 NCI-T90-0226C, T90-0226

Last Modified: 7/1/1991


3.		Phase II Study of DSG in Patients with Refractory Metastatic Breast Cancer (Summary Last Modified 07/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				16 and over				NCI				MDA-DM-90108 NCI-T90-0253C, T90-0253

Last Modified: 8/1/1991


4.		Phase II Study of Deoxyspergualin in Patients with Recurrent Intermediate- and High-Grade non-Hodgkin's Lymphoma (Summary Last Modified 08/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				16 and over				NCI				MSKCC-91053 NCI-T91-0046C, T91-0046

Last Modified: 8/1/1989


5.		Phase I Chemotherapy with Deoxyspergualin in Patients with Advanced Cancer (Summary Last Modified 08/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				MSKCC-8640 NCI-T86-0052W, T86-0052

Last Modified: 7/1/1989


6.		Phase I Chemotherapy with Continuous Infusion Deoxyspergualin in Patients with Solid Tumors (Summary Last Modified 07/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				UTHSC-8565011093 NCI-T85-0276W, T85-0276

Last Modified: 9/1/1992


7.		Phase I Study of DSG Combined with MOAB L6 in Patients with Disseminated Carcinomas (Summary Last Modified 09/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				over 16				NCI				MDA-DM-91009 NCI-T91-0073D, T91-0073

Last Modified: 10/10/2007


8.		Phase I Pilot Study of Intravenous 131I-CC49 Monoclonal Antibody with Deoxyspergualin Immunomodulation in Patients with Advanced Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over								MSKCC-93029 NCI-B92-0002, B92-0002

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute